Question

A patient undergoing therapeutic phlebotomy every two weeks shows a decrease in hemoglobin from 18 mg/dL to 14 mg/dL. As the hemoglobin approaches normal levels, the frequency of phlebotomy needs adjustment to maintain target hemoglobin and prevent anemia. What should be the next step regarding the interval of phlebotomy?

• A. Stop therapy
• B. Once a week
• C. Once in 2 weeks
• D. Once every 4-8 weeks

Hint:

Hemochromatosis Phlebotomy Targets:
Depletion Phase: Weekly/bi-weekly until Ferritin $< 50$ mcg/L.
Maintenance Phase: Every 2-4 months (4-8 weeks) for the rest of the patient's life to maintain Ferritin at $50-100$ mcg/L.

Answer 1

The Correct Option is D

Concept:
A patient with an iron overload syndrome (likely Hereditary Hemochromatosis) has been undergoing aggressive, high-frequency therapeutic phlebotomy to rapidly deplete toxic body iron stores.
The clinical parameters indicate that the patient is successfully transitioning from the initial aggressive "iron depletion phase" into the long-term "maintenance phase," as evidenced by the normalization of hemoglobin. The task is to select the appropriate ongoing treatment frequency.
Explanation:
• The absolute primary and most effective treatment for symptomatic Hereditary Hemochromatosis is therapeutic phlebotomy, which physically removes excess red blood cells, forcing the body to mobilize and consume the toxic, stored tissue iron to synthesize new hemoglobin.

• Treatment protocols are rigidly divided into two distinct clinical phases: the initial induction/depletion phase and the lifelong maintenance phase.

• During the aggressive depletion phase, phlebotomy (removing 400-500 mL of whole blood) is performed frequently, typically once or even twice weekly. The explicit goal is to drive down the serum ferritin levels to a safe target (usually 50-100 $\mu$g/L) while inducing a state of mild, controlled anemia.

• The vignette describes a patient whose hemoglobin has successfully dropped from a high level of 18 mg/dL down to a normal 14 mg/dL. This significant drop strongly indicates that the readily available iron stores are becoming depleted, and the aggressive depletion phase has been successful.

• If the clinician were to continue phlebotomy at the high frequency of every 1 to 2 weeks (Options B and C), the patient would quickly develop severe, symptomatic, and dangerous iron-deficiency anemia.

• Conversely, stopping therapy entirely (Option A) is a major medical error; Hereditary Hemochromatosis is an incurable genetic disorder of continuous iron hyperabsorption. Without ongoing removal, toxic iron will silently and inevitably re-accumulate over time.

• Therefore, the patient must be safely transitioned into the maintenance phase.

• The standard, guideline-directed maintenance phase requires reducing the frequency of phlebotomy significantly. For the vast majority of adult male patients, performing a single phlebotomy session once every 2 to 4 months (or once every 4 to 8 weeks, as per Option D) is perfectly sufficient to keep ferritin levels within the safe target range while entirely preventing the development of anemia.
Final Answer:
To prevent severe anemia while keeping iron levels suppressed, the maintenance interval for therapeutic phlebotomy should be spaced out to once every 4-8 weeks.